Literature DB >> 8639761

Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells.

T D Randall1, F E Lund, M C Howard, I L Weissman.   

Abstract

Using a monoclonal antibody to murine CD38, we showed that a population of adult bone marrow cells that expressed the markers Sca-1 and c-kit but lacked the lineage markers Mac-1, GR-1, B220, IgM, CD3, CD4, CD8 and CD5 could be subdivided by the expression of CD38. We showed that CD38high c-kit+ Sca-1+, linlow/-cells sorted from adult bone marrow cultured with interleukin-3 (IL-3), IL-6, and kit-L produced much larger colonies in liquid culture at a greater frequency than their CD38low/- counterparts. In addition, we found that CD36low/ - cells contained most of the day-12 colony-forming units-spleen (CFU-S) but were not long-term reconstituting cells, whereas the population that expressed higher levels of CD38 contained few, but significant, day-12 CFU-S and virtually all the long-term reconstituting stem cells. Interestingly, the CD38high Sca-1+ c-kit+ linlow/- cells isolated from day-E14.5 fetal liver were also found to be long-term reconstituting stem cells. This is in striking contrast to human hematopoietic progenitors in which the most primitive hematopoietic cells from fetal tissues lack the expression of CD38. Furthermore, because antibodies to CD38 could functionally replace antibodies to Thy-1.1 in a stem cell purification procedure, the use of anti-CD38 may be more generally applicable to the purification of hematopoietic stem cells from mouse strains that do not express the Thy-1.1 allele.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8639761

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S.

Authors:  Thanyaphong Na Nakorn; David Traver; Irving L Weissman; Koichi Akashi
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 2.  The stem cell continuum: considerations on the heterogeneity and plasticity of marrow stem cells.

Authors:  Peter J Quesenberry; G Dooner; M Dooner; G Colvin
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Awakening dormant haematopoietic stem cells.

Authors:  Andreas Trumpp; Marieke Essers; Anne Wilson
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

4.  Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect.

Authors:  Michelle B Bowie; Kristen D McKnight; David G Kent; Lindsay McCaffrey; Pamela A Hoodless; Connie J Eaves
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

Review 5.  Stem cell plasticity revisited: the continuum marrow model and phenotypic changes mediated by microvesicles.

Authors:  Peter J Quesenberry; Mark S Dooner; Jason M Aliotta
Journal:  Exp Hematol       Date:  2010-04-09       Impact factor: 3.084

Review 6.  Hematopoietic Stem Cell Heterogeneity.

Authors:  Roland Jurecic
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 7.  Concise reviews: A stem cell apostasy: a tale of four H words.

Authors:  Peter J Quesenberry; Laura R Goldberg; Mark S Dooner
Journal:  Stem Cells       Date:  2015-01       Impact factor: 6.277

Review 8.  The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles.

Authors:  Peter J Quesenberry; Jason M Aliotta
Journal:  Stem Cell Rev       Date:  2008-07-30       Impact factor: 5.739

9.  Limiting dilution analysis of murine epidermal stem cells using an in vivo regeneration assay.

Authors:  Lauren R Strachan; Ruby Ghadially
Journal:  Methods Mol Biol       Date:  2010

10.  Leucine-rich repeat-containing G-protein-coupled Receptor 5 marks short-term hematopoietic stem and progenitor cells during mouse embryonic development.

Authors:  Donghua Liu; Xi C He; Pengxu Qian; Nick Barker; Paul A Trainor; Hans Clevers; Huiwen Liu; Linheng Li
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.